News | January 10, 2024
Lupin Launches Bromfenac Ophthalmic Solution, 0.07% in US
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Launch innovative vitamin sublingual sprays
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Arco Lab now holds a 50% stake in Neviton
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
